NCT07130201

Brief Summary

This study explores the relationship between sleep disorders and autonomic dysfunction in elderly patients with cardiovascular disease. It examines common risk factors such as aging-related physiological changes, comorbidities, and lifestyle factors, and discusses how disturbances in sleep and autonomic regulation can worsen cardiovascular outcomes. The work also outlines potential clinical implications, including the importance of early screening, integrated management strategies, and targeted interventions to improve both cardiovascular health and quality of life in this vulnerable population.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Sep 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Sep 2025Dec 2027

First Submitted

Initial submission to the registry

August 12, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 19, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

September 20, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2027

Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

1.9 years

First QC Date

August 12, 2025

Last Update Submit

September 18, 2025

Conditions

Cardiovascular Diseases

Outcome Measures

Primary Outcomes (1)

  • Prevalence of sleep disturbance

    Prevalence of sleep disturbance among elderly patients with cardiovascular diseases

    Baseline

Study Arms (1)

Study group

Patients with cardiovascular diseases

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with cardiovascular diseases more than 65 years old

You may qualify if:

  • \- Patients will be recruited from the outpatient clinic (to include stable patients) Age ≥ 65 years Clinically diagnosed cardiovascular disease (e.g., heart failure, atrial fibrillation, coronary artery disease) Able to provide informed consent

You may not qualify if:

  • Diagnosed neurodegenerative diseases (e.g., advanced dementia) Use of sedatives/hypnotics in the past 2 weeks Terminal illness or palliative care status

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cardiovascular Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 12, 2025

First Posted

August 19, 2025

Study Start

September 20, 2025

Primary Completion (Estimated)

August 20, 2027

Study Completion (Estimated)

December 20, 2027

Last Updated

September 23, 2025

Record last verified: 2025-09